Merrimack Pharmaceuticals
MACK
#7785
Rank
HK$1.73 B
Marketcap
HK$117.62
Share price
0.00%
Change (1 day)
21.47%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -HK$0.86

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$0.86. In 2022 the company made an earnings per share (EPS) of -HK$0.86 an increase over its 2021 EPS that were of -HK$1.40.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$0.860.81%
2022-HK$0.86-38.89%
2021-HK$1.40-25%
2020-HK$1.87-81.54%
2019-HK$10.11-56.95%
2018-HK$23.48-108.5%
2017HK$276.06-390.35%
2016-HK$95.08-7.35%
2015-HK$102.6265%
2014-HK$62.19-39.39%
2013-HK$102.62-54.01%
2012-HK$223.12-53.71%
2011-HK$482.0240.37%
2010-HK$343.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$24.72-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-HK$6.53 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.64 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$14.69 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$43.85 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA